VRCA – verrica pharmaceuticals inc. (US:NASDAQ)
Stock Stats
News
Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $8.00 price target on the stock.
Strong week for Verrica Pharmaceuticals (NASDAQ:VRCA) shareholders doesn't alleviate pain of three-year loss [Yahoo! Finance]
Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA [Yahoo! Finance]
Form ARS Verrica Pharmaceuticals For: Dec 31
Form DEFA14A Verrica Pharmaceuticals
Form DEF 14A Verrica Pharmaceuticals For: Jun 06
Form 4 Verrica Pharmaceuticals For: Mar 15 Filed by: Kohler Terry
Form 4 Verrica Pharmaceuticals For: Mar 15 Filed by: White Ted
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.